Piscataway, NJ, June 15, 2021– Camber Pharmaceuticals is pleased to announce that it has launched Lansoprazole DR Capsules to their current portfolio, which is the generic version of Prevacid®
Lansoprazole DR Capsules are used to treat acid-related throat problems (erosive esophagitis).
Lansoprazole DR Capsules from Camber are available in 15 mg and 30 mg strengths. The 15 mg strength is available in 30, 90 and 500 count bottles. The 30 mg strength is available in 90 and 500 count bottles.
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected].
- Camber Pharmaceuticals Launches Generic Namenda®
- 28 New Generics in 2022 and Anticipates Record Number of Approvals in 2023
- Camber Pharmaceuticals Launches Generic Cambia®
- Camber Pharmaceuticals Launches Generic Kuvan® Tablets and Powder for Oral Solution
- Camber Pharmaceuticals Launches Generic Vimpat® Injection
- Camber Pharmaceuticals Launches Generic Naprosyn®